Results 171 to 180 of about 346,833 (254)
Vedolizumab and the gut-CNS axis in multiple sclerosis: considering T cell licensing pathways. [PDF]
Ther Adv Neurol DisordShirani A, Stuve O.
europepmc +1 more source
A Renal Clearable Probe for In Vivo Monoamine Oxidase (MAO) Detection
Advanced Science, EarlyView.A renal‐clearable Cy7‐based fluorogenic probe enables rapid and non‐invasive detection of monoamine oxidase (MAO) activity in vivo. Upon MAO‐mediated activation, the fluorescent product is efficiently excreted in urine, allowing direct quantification of enzyme overexpression.
Marcia Domínguez +13 more
wiley +1 more source
Predictors of Ability to Work in Multiple Sclerosis. [PDF]
CPT Pharmacometrics Syst PharmacolWellhagen GJ +6 more
europepmc +1 more source
Advanced Science, EarlyView.Resident myonuclei are the molecular “control centers” for large multinuclear muscle fibers. It is presumed that, with aging, these control centers become compromised and contribute to delayed or blunted muscle adaptive potential. This study is a detailed roadmap that exposes how young versus aged myonuclei respond to a hypertrophic loading stimulus ...
Pieter J. Koopmans +8 more
wiley +1 more source
Neurobrucellosis and Multiple Sclerosis: Cause, Confounder, or Coincidence? [PDF]
Rev Soc Bras Med TropKocaaga B +4 more
europepmc +1 more source
Extracellular Vesicles in Autoimmune Diseases: From Diagnostic Biomarkers to Engineered Therapeutics
Advanced Science, EarlyView.This review provides a systematic comparison of extracellular vesicles (EVs) from both mammalian and plant sources in the context of autoimmune diseases. It highlights their emerging roles as precision biomarkers and engineered therapeutic platforms.
Yufei Wu +6 more
wiley +1 more source
Stomatitis, Agranulocytosis, and Multiple Sclerosis in Pregnancy. [PDF]
CureusPayano K, Samuel A, Bryant KB.
europepmc +1 more source